Point Therapeutics Inc Sample Contracts

AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 9th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2012, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

HEMASURE INC. and
Stockholders' Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
RECITALS:
Agreement and Plan of Merger • December 18th, 2007 • Point Therapeutics Inc • Pharmaceutical preparations
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.
Security Agreement • February 12th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February__________, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on February __________, 20191 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

AND
Warrant Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 30, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

ARTICLE I DEFINITIONS
Manufacturing Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.
Common Stock Purchase Warrant • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 2014 (the “Initial Exercise Date”)1 and on or prior to the close of business on _________, 20192 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

HEMASURE INC.
Convertible Note • March 31st, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
HEMASURE INC.
Registration Rights Agreement • March 31st, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
BETWEEN HEMASURE INC. AND
Intellectual Property Security Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • Massachusetts
SUMMIT ROUNDTABLE
Consulting Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus
AutoNDA by SimpleDocs
Contract
Securities Purchase Agreement • April 18th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of _______, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 26th, 2010 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October , 2010, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Mr. Richard A. Franco, Sr. Chief Executive Officer DARA BioSciences, Inc.
Placement Agent Agreement • September 14th, 2009 • DARA BioSciences, Inc. • Pharmaceutical preparations • Georgia
EMPLOYMENT AGREEMENT --------------------
Employment Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus • Massachusetts
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.
Common Stock Purchase Warrant • May 22nd, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 2014 (the “Initial Exercise Date”) 1 and on or prior to the close of business on _________, 2019 2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

HEMASURE INC.
Placement Agency Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN HEMASURE INC. AND COBE LABORATORIES, INC.
Exclusive Distribution Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 29th, 2010 • DARA BioSciences, Inc. • Pharmaceutical preparations • North Carolina

This Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2010, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 2nd, 2007 • Point Therapeutics Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2007, among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 1st, 2004 • Point Therapeutics Inc • Pharmaceutical preparations • New York

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 24, 2004, by and among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Investor” and collectively, the “Investors”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!